Skip to Content

Clinical Trials Search Results

Showing 1-3 of 3

Sorted By:

  • A081105

    Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)

  • Alliance A151216

    Genetic Testing For Patients with Resectable or Resected Lung Cancer

  • ECOG E4512

    A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

Showing trials 1-3 of 3

Also in this Section